Modification of deoxyribose-phosphate residues by extracts of ataxia telangiectasia cells. 1990

L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts, Great Britain.

The release of DNA 5'-terminal deoxyribose-phosphate residues from enzymatically incised apurinic/apyrimidinic sites by human cell extracts has been under investigation. During the course of these studies, we observed that ataxia telangiectasia cell extracts modify deoxyribose-phosphate (dRp) residues by converting them to an altered form, dRp-X, which shows altered chromatographic properties on HPLC analysis. The chemical nature of the adduct is as yet unknown, but dRp-X is stable to both heat and acid. The modification requires an enzymatic activity and a low-molecular weight co-factor. Extracts of normal cells contain a dialyzable inhibitor that suppresses the reaction occurring with ataxia telangiectasia cell extracts. Formation of dRp-X has been observed in 7 out of 7 ataxia telangiectasia lymphoblastoid lines which represent at least 3 genetic complementation groups. Similar modification of dRp did not occur with extracts of cells of normal origin, nor those representing Fanconi's anaemia, xeroderma pigmentosum, Bloom's syndrome, Werner's syndrome or Friedreich's ataxia.

UI MeSH Term Description Entries
D010428 Pentosephosphates
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001260 Ataxia Telangiectasia An autosomal recessive inherited disorder characterized by choreoathetosis beginning in childhood, progressive CEREBELLAR ATAXIA; TELANGIECTASIS of CONJUNCTIVA and SKIN; DYSARTHRIA; B- and T-cell immunodeficiency, and RADIOSENSITIVITY to IONIZING RADIATION. Affected individuals are prone to recurrent sinobronchopulmonary infections, lymphoreticular neoplasms, and other malignancies. Serum ALPHA-FETOPROTEINS are usually elevated. (Menkes, Textbook of Child Neurology, 5th ed, p688) The gene for this disorder (ATM) encodes a cell cycle checkpoint protein kinase and has been mapped to chromosome 11 (11q22-q23). Louis-Bar Syndrome,Ataxia Telangiectasia Syndrome,Ataxia-Telangiectasia,Telangiectasia, Cerebello-Oculocutaneous,Louis Bar Syndrome,Syndrome, Ataxia Telangiectasia,Syndrome, Louis-Bar
D012267 Ribosemonophosphates Ribose substituted in the 1-, 3-, or 5-position by a phosphoric acid moiety.
D014020 Tissue Extracts Preparations made from animal tissues or organs (ANIMAL STRUCTURES). They usually contain many components, any one of which may be pharmacologically or physiologically active. Tissue extracts may contain specific, but uncharacterized factors or proteins with specific actions. Extracts, Tissue

Related Publications

L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
April 1986, Experimental cell research,
L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
August 1995, Science (New York, N.Y.),
L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
September 1991, Biochemistry,
L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
August 2009, Neurology,
L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
February 1989, Biochemical and biophysical research communications,
L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
February 2012, Neuropathology : official journal of the Japanese Society of Neuropathology,
L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
October 1983, Carcinogenesis,
L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
April 1968, Bulletin des societes d'ophtalmologie de France,
L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
January 2001, Advances in experimental medicine and biology,
L R Karam, and P Calsou, and W A Franklin, and R B Painter, and M Olsson, and T Lindahl
January 1994, Ryoikibetsu shokogun shirizu,
Copied contents to your clipboard!